SEC Form 4

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION						
Washington, D.C. 20549						
		OMB APPROVAL		
				
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP						
		OMB Number:	3235-0287			
		Estimated average burden		
				
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934		hours per response:	0.5			

or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person*
Troendle August J.

(Last)	(First)	(Middle)

C/O MEDPACE HOLDINGS, INC.

5375 MEDPACE WAY

(Street)			
	CINCINNATI	OH	45227	
				
	(City)	(State)	(Zip)	

2.	Issuer Name and Ticker or Trading Symbol	5. Relationship of Reporting Person(s) to Issuer		
	Medpace Holdings, Inc. [ MEDP ]	(Check all applicable)			
							
				X   Director	X   10% Owner		
							
				X	Officer (give title	Other (specify		
3.	Date of Earliest Transaction (Month/Day/Year)					
			below)	below)		
04/25/2023						
			CEO			

4.	If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable		
Line)

X	Form filed by One Reporting Person

Form filed by More than One Reporting

Person

Rule 10b5-1(c) Transaction Indication

X	Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

	1. Title of Security (Instr. 3)	2. Transaction	2A. Deemed	3.	4. Securities Acquired (A) or		5. Amount of	6. Ownership	7. Nature of		
				Date	Execution Date,	Transaction	Disposed Of (D) (Instr. 3, 4 and 5)	Securities	Form: Direct	Indirect		
				(Month/Day/Year)  if any			Code (Instr.						Beneficially	(D) or Indirect	Beneficial		
						(Month/Day/Year)	8)						Owned Following	(I) (Instr. 4)	Ownership		
															Reported			(Instr. 4)		
																				
									Code  V	Amount	(A) or	Price		Transaction(s)							
											(D)			(Instr. 3 and 4)							

																			By		
	Common Stock		04/25/2023			S(1)	31,648	D	$221.83(2)	6,451,371		I	Medpace		
													Investors,		
																					
																			LLC(3)		
	Common Stock													806,643		D					
													
			Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned							
				(e.g., puts, calls, warrants, options, convertible securities)										
															
	1. Title of	2.	3. Transaction	3A. Deemed	4.	5. Number  6. Date Exercisable and	7. Title and	8. Price of	9. Number of	10.	11. Nature		
	Derivative	Conversion	Date	Execution Date,	Transaction	of	Expiration Date	Amount of	Derivative	derivative		Ownership  of Indirect		
	Security	or Exercise	(Month/Day/Year)	if any	Code (Instr.	Derivative	(Month/Day/Year)	Securities	Security	Securities		Form:	Beneficial		
	(Instr. 3)	Price of		(Month/Day/Year)	8)	Securities			Underlying	(Instr. 5)	Beneficially	Direct (D)	Ownership		
		Derivative					Acquired			Derivative			Owned		or Indirect	(Instr. 4)		
		Security					(A) or			Security (Instr.			Following		(I) (Instr. 4)		
							Disposed			3 and 4)			Reported							
							of (D)								Transaction(s)						
							(Instr. 3, 4								(Instr. 4)							
							and 5)															
																							
												Amount										
												or										
												Number										
									Date	Expiration		of										
						Code  V	(A)   (D)	Exercisable  Date	Title	Shares										

Explanation of Responses:

1.	The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on February 20, 2023.

2.	The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $220.00 to $230.94. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

3.	The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

/s/ Stephen P. Ewald,

Attorney-in-Fact for August J. 04/27/2023

Troendle

** Signature of Reporting Person	Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.